The vsa shield of mycoplasma pulmonis is antiphagocytic

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 704-709

  Shaw, Brandon M ^a   Simmons, Warren L ^a   Dybvig, Kevin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT; CYTOCHALASIN D; UNCLASSIFIED DRUG; VSA PROTEIN;

ACTIN POLYMERIZATION; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BIOFILM; CONTROLLED STUDY; DNA REPLICATION; LYSIS; MACROPHAGE; MYCOPLASMA PULMONIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TANDEM REPEAT;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; CELL LINE; GENE EXPRESSION REGULATION, BACTERIAL; MACROPHAGES, ALVEOLAR; MICE; MYCOPLASMA INFECTIONS; MYCOPLASMA PULMONIS; PHAGOCYTOSIS; PROTEIN BINDING; TANDEM REPEAT SEQUENCES; TIME FACTORS;

EID: 84857187551     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06009-11     Document Type: Article

References (47)

1. Beletskii A, et al. 2005. High-throughput phagocytosis assay utilizing a pH-sensitive fluorescent dye. Biotechniques 39:894-897.
2. Bhugra B, Dybvig K. 1992. High-frequency rearrangements in the chromosome of Mycoplasma pulmonis correlate with phenotypic switching. Mol. Microbiol. 6:1149 -1154.
3. Bhugra B, Voelker LL, Zou N, Yu H, Dybvig K. 1995. Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol. Microbiol. 18:703-714.
4. Campbell PA, Canono BP, Drevets DA. 1994. Measurement of bacterial ingestion and killing by macrophages, p 14.16.11-14.16.13. In Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (ed), Current protocols in immunology, vol 3. John Wiley & Sons, Inc, Hoboken, NJ.
5. Chambaud I, et al. 2001. The complete genome of the murine respiratory pathogen Mycoplasma pulmonis. Nucleic Acids Res. 29:2145-2153.
6. Citti C, Kim MF, Wise KS. 1997. Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growthinhibiting host antibodies. Infect. Immun. 65:1773-1785.
7. Cowman AF, et al. 1985. Conserved sequences flank variable tandem repeats in two S-antigen genes of Plasmodium falciparum. Cell 40:775-783.
8. 2 is associated with damaged alveolar macrophages. Am. Rev. Respir. Dis. 145:406-411.
9. Davis JK, Delozier KM, Asa DK, Minion FC, Cassell GH. 1980. Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro. Infect. Immun. 29:590 -599.
10. Denison AM, Clapper B, Dybvig K. 2005. Avoidance of the host immune system through phase variation in Mycoplasma pulmonis. Infect. Immun. 73:2033-2039.
11. Duncan LR, Gay LS, Donelson JE. 1991. African trypanosomes express an immunogenic protein with a repeating epitope of 24 amino acids. Mol. Biochem. Parasitol. 48:11-16.
12. Dybvig K, Alderete J, Cassell GH. 1988. Adsorption of Mycoplasma pulmonis virus P1 to host cells. J. Bacteriol. 170:4373-4375.
13. Dybvig K, Cassell GH. 1987. Transposition of gram-positive transposon Tn916 in Acholeplasma laidlawii and Mycoplasma pulmonis. Science 235: 1392-1394.
14. Dybvig K, Lao P, Jordan DS, Simmons WL. 2010. Fewer essential genes in mycoplasmas than previous studies suggest. FEMS Microbiol. Lett. 311: 51-55.
15. Elliott JA, Winn WCJ. 1986. Treatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila. Infect. Immun. 51:31-36.
16. Flitman-Tene R, Mudahi-Orenstein S, Levisohn S, Yogev D. 2003. Variable lipoprotein genes of Mycoplasma agalactiae are activated in vivo by promoter addition via site-specific DNA inversions. Infect. Immun. 71:3821-3830.
17. French CT, et al. 2008. Large-scale transposon mutagenesis of Mycoplasma pulmonis. Mol. Microbiol. 69:67-76.
18. Glass JI, et al. 2000. The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature 407:757-762.
19. Glew MD, Marenda M, Rosengarten R, Citti C. 2002. Surface diversity in Mycoplasma agalactiae is driven by site-specific DNA inversions within the vpma multigene locus. J. Bacteriol. 184:5987-5998.
20. Gravekamp C, et al. 1997. Immunogenicity and protective efficacy of the alphaCprotein of group B streptococci are inversely related to the number of repeats. Infect. Immun. 65:5216 -5221.
21. Hickman-Davis J, Gibbs-Erwin J, Lindsey JR, Matalon S. 1999. Surfactant protein A mediates mycoplasmal activity of alveolar macrophages by production of peroxynitrite. Proc. Natl. Acad. Sci. U. S. A. 96:4953-4958.
22. Hickman-Davis J, Michalek SM, Gibbs-Erwin J, Lindsey JR. 1997. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-sensitive C3H mice. Infect. Immun. 65:2278 -2282.
23. Hickman-Davis JM, Lindsey JR, Matalon S. 2001. Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis. Infect. Immun. 69:6401-6410.
24. Hickman-Davis JM, Lindsey JR, Zhu S, Matalon S. 1998. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am. J. Physiol. 274:L270 -L277.
25. Horowitz SA, Garret B, Davis JK, Cassell GH. 1987. Isolation of Mycoplasma pulmonis membranes and identification of surface antigens. Infect. Immun. 55:1314 -1320.
26. Jensen LT, Ladefoged S, Birkelund S, Christiansen G. 1995. Selection of Mycoplasma hominis PG21 deletion mutants by cultivation in the presence of monoclonal antibody 552. Infect. Immun. 63:3336 -3347.
27. Jones TC, Hirsch JG. 1971. The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells. J. Exp. Med. 133: 231-259.
28. Jones TC, Yang L. 1977. Attachment and ingestion of mycoplasmas by mouse macrophages. 1. Kinetics of the interaction and effects on phagocyte glucose metabolism. Am. J. Pathol. 87:331-346.
29. Jones TC, Yeh S, Hirsch JG. 1972. Studies on attachment and ingestion phases of phagocytosis of Mycoplasma pulmonis by mouse peritoneal macrophages. Proc. Soc. Exp. Biol. Med. 139:464-470.
30. Kemp DJ, Coppel RL, Anders RF. 1987. Repetitive proteins and genes of malaria. Annu. Rev. Microbiol. 41:181-208.
31. Madoff LC, Michel JL, Gong EW, Kling DE, Kasper DL. 1996. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc. Natl. Acad. Sci. U. S. A. 93:4131-4136.
32. Mbawuike IN, Herscowitz HB. 1989. MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics. J. Leukoc. Biol. 46:119 -127.
33. Razin S, Yogev D, Naot Y. 1998. Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 62:1094 -1156.
34. Sachse K, et al. 2000. Epitope mapping of immunogenic and adhesive structures in repetitive domains of Mycoplasma bovis variable surface lipoproteins. Infect. Immun. 68:680-687.
35. Sankaran K, Herscowitz HB. 1995. Phenotypic and functional heterogeneity of the murine alveolar macrophage-derived cell line MH-S. J. Leukoc. Biol. 57:562-568.
36. Shen X, et al. 2000. Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J. Bacteriol. 182:2900 -2908.
37. Simmons WL, Bolland JR, Daubenspeck JM, Dybvig K. 2007. A stochastic mechanism for biofilm formation by Mycoplasma pulmonis. J. Bacteriol. 189:1905-1913.
38. Simmons WL, Denison AM, Dybvig K. 2004. Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis. Infect. Immun. 72:6846-6851.
39. Simmons WL, Dybvig K. 2009. Mycoplasma biofilms ex vivo and in vivo. FEMS Microbiol. Lett. 295:77-81.
40. Simmons WL, Dybvig K. 2003. The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene. Infect. Immun. 71:5733-5738.
41. Singh KK, Zhang X, Patibandla AS, Chien P Jr, Laal S. 2001. Antigens of Mycopbacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences. Infect. Immun. 69:4185-4191.
42. Sitaraman R, Denison AM, Dybvig K. 2002. A unique, bifunctional site-specific DNA recombinase from Mycoplasma pulmonis. Mol. Microbiol. 46:1033-1040.
43. Underhill DM, Ozinsky A. 2002. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20:825-852.
44. Waites KB, Talkington DF. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 17:697-728.
45. Washburn LR, Weaver KE, Weaver EJ, Donelan W, Al-Sheboul S. 1998. Molecular characterization of Mycoplasma arthritidis variable surface protein MAA2. Infect. Immun. 66:2576 -2586.
46. Watson HL, Dybvig K, Blalock DK, Cassell GH. 1989. Subunit structure of the variable V-1 antigen of Mycoplasma pulmonis. Infect. Immun. 57: 1684-1690.
47. Yogev D, Rosengarten R, Watson-McKown R, Wise KS. 1991. Molecular basis of Mycoplasma surface antigenic variation: a novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5′ regulatory sequences. EMBO J. 10:4069-4079.